AzTrials
AzTrials

StrokeNCT04015271

Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chronic Stroke Survivors

A study testing Action Observation + Repetitive Task Practice in people with Stroke and Hemiparesis, run by Ohio State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this pilot randomized controlled single blinded, parallel-group study is to detect change of the Action Observation (AO) and Repetitive Task Practice (RTP) combined practice schedule on upper limb motor impairment outcomes in chronic, moderately impaired stroke survivors. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Stroke, Hemiparesis
What is being tested?
Action Observation + Repetitive Task Practice
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteUnited States
Study dates
27 Jun 2019to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Experienced a stroke resulting in a Upper Extremity Fugl Meyer score >17 < 49
  • Experienced a post stroke > 6 months
  • > 24 on the Folstein Mini Mental Status Examination
  • Experienced only one stroke
  • Discharged from all forms of physical rehabilitation intervention
  • Visual acuity of 20/50 or greater with or without corrective lenses
Show all 10Show fewer
  • > 19 on the Hooper Visual Organization Test
  • Unilateral stroke only
  • Cerebral stroke
  • Age of onset of stroke greater than 18 years old.

Who cannot join

  • < 18 years old
  • > 5 on a 10-point visual analog pain scale in the affected UL
  • > 2 on the Modified Ashworth Scale in the affected UL to exclude individuals with hypertonia, spasticity, joint rigidity, and joint contracture
  • Participating in any experimental rehabilitation or drug studies
  • Uncontrolled cardiovascular, or pulmonary disease, or other disease that would preclude involvement in a therapeutic treatment
  • Neurological disorder other than stroke
Show all 9Show fewer
  • > 31 on Beck Depression Inventory ("Severe Depression")
  • Unable to regularly attend treatment sessions and follow-up due to distance from the center or inadequate social support
  • Cerebellar stroke with ataxia

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University

    Columbus, Ohio, 43210

Other trials in United States

About this study

Official title: The Feasibility of Action Observation and Repetitive Task Practice Combined Practice Schedule on Upper Extremity Outcomes in Moderately Impaired Chronic Stroke Survivors

The objective of this pilot randomized controlled single blinded, parallel-group study is to detect change of the Action Observation (AO) and Repetitive Task Practice (RTP) combined practice schedule on upper limb motor impairment outcomes in chronic, moderately impaired stroke survivors.

Read the detailed description

The current proposal aims to conduct a pilot randomized controlled single blinded, parallel-group study design to detect change of the Action Observation (AO) and Repetitive Task Practice (RTP) combined practice schedule on upper limb (UL) motor impairment outcomes in the chronic, moderately impaired stroke survivor. Individuals will be randomized to 1) experimental conditions of AO + RTP practice schedule, or 2) control condition of Placebo Video (PV) + RTP, and will receive an assigned regimen from a blinded intervention therapist for one hour, 3 times per week, for 8 weeks (total of 24 sessions), and a daily 30 minute HEP. A blinded assessor will complete assessments on each subject at three distinct time points of pretest, post intervention, and 1 month post intervention.

Conditions
Stroke, Hemiparesis
Being tested
Action Observation + Repetitive Task Practice, Placebo Video + Repetitive Task Practice
Keywords
stroke, hemiparesis
Medical subject headings
Stroke, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Action Observation + Repetitive Task PracticeBehavioural

    Observing a video of another person performing a functional task and physically repetitively performing the same task for upper extremity hemiparesis

  • Placebo Video + Repetitive Task PracticeBehavioural

    Observing a video of static images and physically repetitively performing functional task for upper extremity hemiparesis

Study groups in NCT04015271
Study groupRoleWhat they receive
Action Observation + Repetitive Task PracticeExperimentalAction Observation (AO) therapy regimen will include watching a 6 minute video of another person completing a specified functional task (Putting on a shirt, pick up a sandwich and bring to mouth, eat food with a spoon, or cut meat with knife and fork). Subjects will be instructed to carefully watch the AO video and prepare to physically perform the task immediately after observing the video. The Repetitive Task Practice (RTP) therapy regimen emphasizes repeated physical performance with the hemiplegic upper limb for 24 minutes of a specified functional task that is matched to the AO recording. The AO + RTP regimens will be repeated for a total of 60 minutes. Each Subject will complete a Home Exercise Program (HEP) will include practicing components and movement patterns of the functional task that was difficult for the patient to perform during RTP intervention for 30 minutes each day outside of scheduled intervention sessions.
Receives: Behavioral: Action Observation + Repetitive Task Practice
Placebo Video + Repetitive Task PracticePlacebo comparatorThe control placebo videos (PV) will be 6 minutes, and will include a series of changing static images without animals, human beings, or sound (i.e. pictures of buildings, trees, cruise ships, mountains, beach umbrellas, beds, and tables). A Repetitive Task Practice (RTP) therapy regimen will be completed immediately after observing the PV, which emphasizes repeated physical performance with the hemiplegic upper limb for 24 minutes of a specified functional task. These tasks include putting on a shirt, picking up a sandwich and bringing it to mouth, eating food with a spoon, or cutting meat with knife and fork. The PV + RTP regimens will be repeated for a total of 60 minutes. Each Subject will complete a Home Exercise Program (HEP) will include practicing components and movement patterns of the functional task that was difficult for the patient to perform during RTP intervention for 30 minutes each day outside of scheduled intervention sessions.
Receives: Behavioral: Placebo Video + Repetitive Task Practice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in Upper extremity section of the Fugl-Meyer Scale

    Assessment to evaluate motor impairment of the hemiplegic upper limb. Multiple time points will be used to asses the change in motor impairment. Items are scored on a 3 point ordinal scale (0 = cannot perform, 2 = can perform fully), and are totaled for a maximum of 66 possible points.

    Measured: Pretest, immediately after the intervention, and 1 month post intervention

Secondary outcomes (11)
  1. Change from Baseline in the The Arm Motor Ability Test

    Assessment to evaluate function during activities of daily living of the hemiplegic upper limb

    Measured: Pretest, immediately after the intervention, and 1 month post intervention

  2. Change from Baseline in the Motor Activity Log

    Assessment to evaluate the activity limitation of hemiplegic upper limb functional use in the community

    Measured: Pretest, immediately after the intervention, and 1 month post intervention

  3. Change from baseline in smoothness of movements measured by three-axis accelerometer

    A Fitbit will be used to quantify the amount of upper limb motor activity during an intervention session and heart rate

    Measured: Each session (3 times per week) during 8 week intervention

  4. Change from Baseline in Stroke Impact Scale 2.0

    Assessment to evaluate motor and functional changes in the hemiplegic upper. It is a 64-item self-report measure assessing 8 domains (strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation).A low score indicates a high impact on quality of life.

    Measured: Pretest, immediately after the intervention, and 1 month post intervention

  5. Survey to assess subjects experience in the study

    A survey to examine the perceived experience of the intervention for subjects participating in the study. Subjects will answer on a 5 point ordinal scale (1 = Strongly disagree, 5 = Strongly Agree), and open ended questions will be descriptive questions to explain response on ordinal scale.

    Measured: immediately after the intervention, and 1 month post intervention

  6. Daily Diary

    A diary to measure everyday application of functional tasks learned in the protocol and compliance with HEP

    Measured: Each day during 8 week intervention

  7. Number of trials/ repetitions per task

    Measurement of the number of times a subject completes a task in a one hour session

    Measured: Each session (3 times per week) during 8 week intervention

  8. Change in Movement time to complete task

    Measure the amount of time required for a subject to complete a task during performance of task

    Measured: Each session (3 times per week) during 8 week intervention

  9. Change in Amount of physical assist to perform task

    Measure how much assistance a subject requires to complete a task. Amount will be measured in the categories of tactile cue, 1 hand assistance, 2 hand assistance

    Measured: Each session (3 times per week) during 8 week intervention

  10. Change in Number of verbal cues given to perform task

    Measure the number of verbal cues that are required for a subject to perform a task

    Measured: Each session (3 times per week) during 8 week intervention

  11. Change in the number of errors during task performance

    Measure the number of errors that a subject demonstrates while performing a task

    Measured: Each session (3 times per week) during 8 week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2019
  2. Study start27 Jun 2019
  3. Primary completion31 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A pilot randomized controlled single blinded, parallel-group study design
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04015271
Sponsor's protocol ID
2019H0197
Status last verified
Mar 2020
First submitted
2 Jul 2019
Last updated
4 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Borges LR, Fernandes AB, Oliveira Dos Passos J, Rego IAO, Campos TF. Action observation for upper limb rehabilitation after stroke. Cochrane Database Syst Rev. 2022 Aug 5;8(8):CD011887. doi: 10.1002/14651858.CD011887.pub3.

    PubMed 35930301

Questions about this trial

What is this clinical trial studying?

A study testing Action Observation + Repetitive Task Practice in people with Stroke and Hemiparesis, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in Upper extremity section of the Fugl-Meyer Scale (time frame: Pretest, immediately after the intervention, and 1 month post intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04015271, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in